Latest Breaking News On - Trevi therapeutics inc - Page 10 : comparemela.com

Trevi Therapeutics (TRVI) Announces Publication of Positive Data from the CANAL Trial

Trevi Therapeutics (TRVI) Announces Publication of Positive Data from the CANAL Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Trevi therapeutics incWall street

Trevi Therapeutics Announces Publication of Positive Data from the CANAL Trial in IPF Chronic Cough in NEJM Evidence

Trevi Therapeutics Announces Publication of Positive Data from the CANAL Trial in IPF Chronic Cough in NEJM Evidence
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomRosalia scampoliToby maherKatie mcmanusUniversity of southern californiaKeck school of medicineExchange commissionCompany on twitterPrnewswire trevi therapeutics incTrevi therapeutics incClinical medicineKeck schoolSouthern californiaTrevi therapeuticsPrivate securities litigation reform act

Trevi Therapeutics, Inc (NASDAQ:TRVI) Q1 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Trevi Therapeutics’ Q1 2023 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

United statesAnnabel samimyTom smithSerge belangerSean kimMayank mamtaniLisa delfiniAmerican thoracic societyTrevi therapeutics incDrug enforcement agencySilicon valley bankNeedham companyFirst citizens bankTrevi therapeuticsCall transcript maySafe harbor

Multichain (MULTI) Hits Self Reported Market Capitalization of $141 91 Million

MAI Capital Management trimmed its holdings in Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) by 14.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,720,676 shares of the company’s stock after selling 298,488 shares during the quarter. MAI Capital Management owned 2.87% of Trevi […]

Northern trust corpExchange commissionVirtu financialJump financialTrevi therapeutics incNeedham companyBailard incTrevi therapeuticsGet ratingStreet corpTrust corpTrevi therapeutics dailyNasdaq trviSec filingsHedge fund holdingsInstitutional investor holdings

Trevi Therapeutics, Inc (NASDAQ:TRVI) Short Interest Update

Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 280,300 shares, an increase of 39.2% from the April 15th total of 201,300 shares. Based on an average daily volume of 81,500 shares, the short-interest ratio is […]

Tejara capital ltdMillennium managementVirtu financialTrevi therapeutics incNeedham companyTrevi therapeuticsGet ratingCapital ltdAtom investorsTrevi therapeutics dailyNasdaq trvi